Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure
Katherine L Modzelewski, Alexandra Pipilas, Nicholas A Bosch
JAMA Netw Open . 2024 May 1;7(5):e249305.
doi.org/10.1001/jamanetworkopen.2024.9305
The value of loss of protective pain sensation in predicting a first ulceration of the foot in people with diabetes
Anna Trocha, Veronika Gontscharuk, Andrea Icks, William Jeffcoate
Diabet Med. 2024 Apr;41(4):e15241. d
https://doi.org/10.1111/dme.15241
Point-of-Care HbA1c in Clinical Practice: Caveats and Considerations for Optimal Use
David B Sacks, M Sue Kirkman, Randie R Little.
Diabetes Care. 2024 Mar 29:dci230040.
doi: 10.2337/dci23-0040.
Maternal and neonatal outcomes according to the timing of diagnosis of hyperglycaemia in pregnancy: a nationwide cross-sectional study of 695,912 deliveries in France in 2018Nolwenn Regnault, Elodie Lebreton, Luveon Tang
Diabetologia. 2024 Mar;67(3):516-527.
doi: 10.1007/s00125-023-06066-4
Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes
Timothy C Dunn, Ramzi A Ajjan, Richard M Bergenstal, Yongjin XuDiabetes Technol Ther. 2024 Mar;26(3):203-210.
doi: 10.1089/dia.2023.0565
Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations
Jane Speight, Elizabeth Holmes-Truscott, Matthew Garza, et al.
Lancet Diabetes Endocrinol. 2024 Jan;12(1):61-82.
doi: 10.1016/S2213-8587(23)00347-9.
Comentarios recientes